Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

The landscape of global health is complex and constantly evolving, presenting immense challenges in resource allocation, ...

It’s been five years since the U.K.’s breakup with the European Union, and the impacts of extra red tape and rising costs ...

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

Lilly, Johnson & Johnson, Novartis and AstraZeneca have now announced manufacturing investments in the U.S., trying to ...